Trials / Conditions / Choroidal Melanoma

Choroidal Melanoma

17 registered clinical trials studyying Choroidal Melanoma — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma NCT07338968	Aura Biosciences	—
Recruiting	Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects NCT07421739	Aura Biosciences	—
Recruiting	A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-0 NCT06007690	Aura Biosciences	Phase 3
Terminated	Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Prima NCT05266430	Aura Biosciences	—
Completed	Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With P NCT04417530	Aura Biosciences	Phase 2
Recruiting	A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma NCT03941379	Aura Biosciences	—
Completed	Study in Subjects With Small Primary Choroidal Melanoma NCT03052127	Aura Biosciences	Phase 1 / Phase 2
Completed	Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU) NCT02875652	Institut Curie	N/A
Completed	Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melano NCT01460810	University of Colorado, Denver	N/A
Completed	Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2) NCT01251978	New England Retina Associates	Phase 2
Completed	Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Th NCT01253759	New England Retina Associates	—
Completed	Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melan NCT00750399	The New York Eye Cancer Center	Phase 1
Completed	Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma NCT00765921	Massachusetts Eye and Ear Infirmary	Phase 1
Completed	Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma NCT00680225	New England Retina Associates	Phase 3
Completed	Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone NCT00351728	Jonsson Comprehensive Cancer Center	—
Completed	Cytogenetic Study of Ocular Melanoma NCT00344799	Jonsson Comprehensive Cancer Center	—
Unknown	Pain Relief - Tramadol Versus Ibuprofen NCT00111046	Royal Liverpool University Hospital	Phase 1 / Phase 2